Hence then, the article about abbvie submits supplemental new drug application to u s fda to support new indication of linzess linaclotide for functional constipation in children and adolescents 6 to 17 years of age was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( AbbVie Submits Supplemental New Drug Application to U.S. FDA to Support New Indication of LINZESS® (linaclotide) for Functional Constipation in Children and Adolescents 6 to 17 Years of Age )
Also on site :
- Stockton high school teacher arrested in child sexual abuse material case, CHP says
- Wired for War: The empire’s propaganda wing honors Palantir
- Paige DeSorbo on Healing From Domestic Violence With Her Pet: ‘Sometimes the Thing That Helps You Feel Safe Again Has Four Paws’